Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 70 | $85,302,160 |
| Sells | 149 | $910,143,209 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Mar 2025 21:01 | PDEX | PRO DEX INC | CABILLOT RAYMOND E | Director , 10% | 31 Mar 2025 | Sale | 836 | 50 | 41,800 | I |
| 31 Mar 2025 21:01 | PDEX | PRO DEX INC | CABILLOT RAYMOND E | Director , 10% | 28 Mar 2025 | Sale | 842 | 50 | 42,100 | I |
| 31 Mar 2025 20:49 | AEVA | Aeva Technologies Inc | SYLEBRA CAPITAL LLC | 10% | 31 Mar 2025 | Purchase | 1,068,297 | 6.77 | 7,232,371 | I |
| 31 Mar 2025 20:49 | AEVA | Aeva Technologies Inc | SYLEBRA CAPITAL LLC | 10% | 28 Mar 2025 | Purchase | 1,333,188 | 6.7 | 8,932,360 | I |
| 31 Mar 2025 20:49 | AEVA | Aeva Technologies Inc | SYLEBRA CAPITAL LLC | 10% | 27 Mar 2025 | Purchase | 1,157,742 | 6.15 | 7,120,113 | I |
| 31 Mar 2025 20:48 | OKLO | Oklo Inc | JANSEN JOHN M | Director | 27 Mar 2025 | Purchase | 6,000 | 24.5686 | 147,412 | D |
| 31 Mar 2025 20:46 | OKLO | Oklo Inc | DEWITTE JACOB | Co-Founder, CEO, 10% | 31 Mar 2025 | Sale | 41,000 | 21.8036 | 893,948 | D |
| 31 Mar 2025 20:46 | OKLO | Oklo Inc | DEWITTE JACOB | Co-Founder, CEO, 10% | 28 Mar 2025 | Sale | 35,231 | 23.5827 | 830,842 | D |
| 31 Mar 2025 20:46 | OKLO | Oklo Inc | DEWITTE JACOB | Co-Founder, CEO, 10% | 28 Mar 2025 | Sale | 104,404 | 22.6445 | 2,364,176 | D |
| 31 Mar 2025 20:46 | OKLO | Oklo Inc | DEWITTE JACOB | Co-Founder, CEO, 10% | 27 Mar 2025 | Sale | 14,635 | 26.004 | 380,569 | D |
| 31 Mar 2025 20:46 | OKLO | Oklo Inc | DEWITTE JACOB | Co-Founder, CEO, 10% | 27 Mar 2025 | Sale | 20,730 | 24.5408 | 508,731 | D |
| 31 Mar 2025 20:45 | OKLO | Oklo Inc | COCHRAN CAROLINE | Co-Founder, COO, 10% | 31 Mar 2025 | Sale | 41,000 | 21.8036 | 893,948 | I |
| 31 Mar 2025 20:45 | OKLO | Oklo Inc | COCHRAN CAROLINE | Co-Founder, COO, 10% | 28 Mar 2025 | Sale | 35,231 | 23.5827 | 830,842 | I |
| 31 Mar 2025 20:45 | OKLO | Oklo Inc | COCHRAN CAROLINE | Co-Founder, COO, 10% | 28 Mar 2025 | Sale | 104,404 | 22.6445 | 2,364,176 | I |
| 31 Mar 2025 20:45 | OKLO | Oklo Inc | COCHRAN CAROLINE | Co-Founder, COO, 10% | 27 Mar 2025 | Sale | 14,635 | 26.004 | 380,569 | I |
| 31 Mar 2025 20:45 | OKLO | Oklo Inc | COCHRAN CAROLINE | Co-Founder, COO, 10% | 27 Mar 2025 | Sale | 20,730 | 24.5408 | 508,731 | I |
| 31 Mar 2025 20:20 | GMGI | Golden Matrix Group Inc | MCCHESNEY THOMAS | Director | 28 Mar 2025 | Sale A | 4,743 | 2.05 | 9,723 | D |
| 31 Mar 2025 20:20 | GMGI | Golden Matrix Group Inc | MCCHESNEY THOMAS | Director | 27 Mar 2025 | Sale A | 257 | 2.13 | 547 | D |
| 31 Mar 2025 20:20 | GMGI | Golden Matrix Group Inc | MCCHESNEY THOMAS | Director | 26 Mar 2025 | Sale A | 7,500 | 2.12 | 15,900 | D |
| 31 Mar 2025 20:05 | ZVRA | ZEVRA THERAPEUTICS Inc | WATTON COREY MICHAEL | Director | 28 Mar 2025 | Purchase | 300 | 7.8384 | 2,352 | D |
| 31 Mar 2025 19:37 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 3,250 | 21.3295 | 69,321 | D |
| 31 Mar 2025 19:33 | PLMR | Palomar Holdings Inc | UCHIDA T CHRISTOPHER | Chief Financial Officer | 31 Mar 2025 | Sale | 1,000 | 139 | 139,000 | D |
| 31 Mar 2025 19:24 | SLNO | SOLENO THERAPEUTICS INC | PAULS MATTHEW | Director | 28 Mar 2025 | Sale | 5,937 | 71.5508 | 424,797 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 23,475 | 66.9528 | 1,571,717 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 50,156 | 65.9957 | 3,310,080 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 91 | 72.6391 | 6,610 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 597 | 71.7433 | 42,831 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 411 | 70.7341 | 29,072 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 3,990 | 69.8371 | 278,650 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 6,891 | 68.7881 | 474,019 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 5,239 | 67.7007 | 354,684 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 2,881 | 66.7916 | 192,427 | D |
| 31 Mar 2025 19:23 | SLNO | SOLENO THERAPEUTICS INC | YEN KRISTEN | SEE REMARKS | 27 Mar 2025 | Sale | 1,769 | 65.9691 | 116,699 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 37,000 | 67.0388 | 2,480,436 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 34 | 72.6391 | 2,470 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 225 | 71.7433 | 16,142 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 155 | 70.7341 | 10,964 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 1,505 | 69.8371 | 105,105 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 2,599 | 68.7881 | 178,780 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 1,976 | 67.7007 | 133,777 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 1,087 | 66.7916 | 72,602 | D |
| 31 Mar 2025 19:21 | SLNO | SOLENO THERAPEUTICS INC | MANNING MEREDITH | Chief Commercial Officer | 27 Mar 2025 | Sale | 668 | 65.9691 | 44,067 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 8,044 | 70.7974 | 569,494 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 36,157 | 70.0257 | 2,531,919 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 25,799 | 69.0733 | 1,782,022 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 86 | 72.6391 | 6,247 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 563 | 71.7433 | 40,391 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 387 | 70.7341 | 27,374 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 3,762 | 69.8371 | 262,727 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 6,498 | 68.7881 | 446,985 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 4,940 | 67.7007 | 334,441 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 2,717 | 66.7916 | 181,473 | D |
| 31 Mar 2025 19:20 | SLNO | SOLENO THERAPEUTICS INC | MACKANESS JAMES H | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 1,669 | 65.9691 | 110,102 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 10,000 | 70.033 | 700,330 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 19 | 72.6391 | 1,380 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 125 | 71.7433 | 8,968 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 86 | 70.7341 | 6,083 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 836 | 69.8371 | 58,384 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 1,444 | 68.7881 | 99,330 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 1,098 | 67.7007 | 74,335 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 604 | 66.7916 | 40,342 | D |
| 31 Mar 2025 19:18 | SLNO | SOLENO THERAPEUTICS INC | HUANG MICHAEL F. | Sr. VP of Clinical Development | 27 Mar 2025 | Sale | 371 | 65.9691 | 24,475 | D |
| 31 Mar 2025 19:17 | ABEO | ABEONA THERAPEUTICS Inc | SESHADRI VISHWAS | Chief Executive Officer | 31 Mar 2025 | Sale | 25,000 | 4.78 | 119,500 | D |
| 31 Mar 2025 19:05 | GWRS | Global Water Resources Inc | COHN ANDREW M. | Director | 27 Mar 2025 | Purchase | 252,000 | 10 | 2,520,000 | D |
| 31 Mar 2025 19:04 | GWRS | Global Water Resources Inc | LEVINE JONATHAN L | Director | 27 Mar 2025 | Purchase | 1,187,200 | 10 | 11,872,000 | I |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 28 Mar 2025 | Sale | 2,691 | 73.6 | 198,058 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 28 Mar 2025 | Sale | 9,253 | 69.5176 | 643,246 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 28 Mar 2025 | Sale | 12,324 | 68.9213 | 849,386 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 28 Mar 2025 | Sale | 3,394 | 67.456 | 228,946 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 15,145 | 72.5 | 1,098,012 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 24,989 | 70.176 | 1,753,628 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 24,776 | 67.4697 | 1,671,629 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 46,214 | 66.39 | 3,068,147 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 73 | 72.6391 | 5,303 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 478 | 71.7433 | 34,293 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 329 | 70.7341 | 23,272 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 3,198 | 69.8371 | 223,339 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 5,524 | 68.7881 | 379,985 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 4,199 | 67.7007 | 284,275 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 2,310 | 66.7916 | 154,289 | D |
| 31 Mar 2025 19:01 | SLNO | SOLENO THERAPEUTICS INC | HIRANO PATRICIA C | SEE REMARKS | 27 Mar 2025 | Sale | 1,418 | 65.9691 | 93,544 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 199,226 | 69.2977 | 13,805,904 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 8,423 | 67.37 | 567,458 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 209,689 | 66.3306 | 13,908,797 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 106,471 | 65.8119 | 7,007,059 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 732 | 72.6391 | 53,172 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 4,782 | 71.7433 | 343,076 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 3,291 | 70.7341 | 232,786 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 31,980 | 69.8371 | 2,233,390 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 55,234 | 68.7881 | 3,799,442 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 41,989 | 67.7007 | 2,842,685 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 23,095 | 66.7916 | 1,542,552 | D |
| 31 Mar 2025 19:00 | SLNO | SOLENO THERAPEUTICS INC | ANISH BHATNAGAR | CHIEF EXECUTIVE OFFICER | 27 Mar 2025 | Sale | 14,183 | 65.9691 | 935,640 | D |
| 31 Mar 2025 18:57 | RFIL | R F INDUSTRIES LTD | HOLDSWORTH MARK KEITH | Director | 27 Mar 2025 | Purchase | 10,000 | 4.741 | 47,410 | D |
| 31 Mar 2025 18:57 | RFIL | R F INDUSTRIES LTD | HOLDSWORTH MARK KEITH | Director | 27 Mar 2025 | Purchase | 5,000 | 4.679 | 23,395 | D |
| 31 Mar 2025 18:56 | PODC | PodcastOne Inc | MERRIMAN D JONATHAN | Director | 31 Mar 2025 | Purchase | 5,200 | 1.51 | 7,852 | I |
| 31 Mar 2025 18:56 | PODC | PodcastOne Inc | MERRIMAN D JONATHAN | Director | 28 Mar 2025 | Purchase | 4,500 | 1.46 | 6,570 | I |
| 31 Mar 2025 18:56 | PODC | PodcastOne Inc | MERRIMAN D JONATHAN | Director | 27 Mar 2025 | Purchase | 3,200 | 1.51 | 4,832 | I |
| 31 Mar 2025 18:53 | GCO | GENESCO INC | FUND 1 INVESTMENTS, LLC | 10% | 28 Mar 2025 | Sale | 12,000 | 20.7299 | 248,759 | I |
| 31 Mar 2025 18:53 | GDRZF | GOLD RESERVE LTD | CAMAC CAPITAL, LLC | 10% | 28 Mar 2025 | Purchase | 25,000 | 1.76 | 44,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)